Not logged in Share Save
Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study Antoniotti, C.; Carullo, M.; Rossini, D.; Pietrantonio, F.; Salvatore, L.; Lonardi, S.; Tamberi, S.; Sciortino, C.; Conca, V.; Calegari, M. A.; Ciraci, P.; Tamburini, E.; Bergamo, F.; Boccaccio, C.; Passardi, A.; Ritorto, G.; Ugolini, C.; Aprile, G.; Galon, J.; Cremolini, C. Share Save
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference Laurent, Pierre-Antoine; Andre, Fabrice; Bobard, Alexandre; Deandreis, Desiree; Demaria, Sandra; Depil, Stephane; Eichmueller, Stefan B.; Fernandez-Palomo, Cristian; Foijer, Floris; Galluzzi, Lorenzo; Galon, Jerome; Guckenberger, Matthias; Harrington, Kevin J.; Herrera, Fernanda G.; Huber, Peter E.; Italiano, Antoine; Karam, Sana D.; Kroemer, Guido; Lambin, Philippe; Leuschner, Carola; Mantovani, Alberto; Meylan, Etienne; Mondini, Michele; Pittet, Mikael J.; Pouget, Jean-Pierre; Remon, Jordi; Sorensen, Claus S.; Sotiriou, Christos; Vanpouille-Box, Claire; Weichselbaum, Ralph R.; Welsh, James W.; Zitvogel, Laurence; Formenti, Silvia C.; Deutsch, Eric Share Save
Combining immunoscore and tumor budding in colon cancer: an insightful prognostication based on the tumor-host interface Haddad, T. S.; Bokhorst, J. M.; Berger, M. D.; Dobbelsteen, L. v. d.; Simmer, F.; Ciompi, F.; Galon, J.; Laak, J. v. d.; Pages, F.; Zlobec, I.; Lugli, A.; Nagtegaal, I. D. Share Save
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring Berthe, Julie; Poudel, Pawan; Segerer, Felix J.; Jennings, Emily C.; Ng, Felicia; Surace, Michael; Andoni, Alma; Testori, Marco; Saraiya, Megha; Vuko, Miljenka; Hessel, Harald; Heininen-Brown, Mari; Blando, Jorge; Jones, Emma V.; Willis, Sophie E.; Galon, Jerome; van de Ven, Rieneke; de Gruijl, Tanja D.; Angell, Helen K. Share Save
Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Characterization of the circulating immune response in the AVETUXIRI phase II trial Benidovskaya, E.; Huyghe, N.; Carrasco, J.; De Cuyper, A.; Sinapi, I.; Verstraelen, E.; Goffette, P.; Ghaye, B.; Papier, M.; van Maanen, A.; Castella, M-L.; Galon, J.; van den Eynde, M. Share Save
The presence of liver metastases does not predict resistance to immunotherapy in proficient MMR metastatic colorectal cancer (mCRC): A secondary analysis of the AtezoTRIBE study Carullo, M.; Antoniotti, C.; Rossini, D.; Marmorino, F.; Raimondi, A.; Salvatore, L.; Lonardi, S.; Tamberi, S.; Vetere, G.; Prisciandaro, M.; Schietroma, F.; Ramundo, M.; Pircher, C. C.; Conca, V.; Perissinotto, E.; Passardi, A.; Aprile, G.; Ugolini, C.; Galon, J.; Cremolini, C. Share Save
Combined analyses of ctDNA and Immunoscore in stage III colon cancer patients: A post hoc analysis of the IDEA-France and -Greece trials Taieb, J.; Souglakos, I.; Boukovinas, I.; Falcoz, A.; Messaritakis, I.; Bennouna, J.; Artru, P.; Pages, F.; Louvet, C.; Lepere, C.; Emile, J. F.; Bouche, O.; Mazard, T.; Sharma, S.; Vernerey, D.; Andre, T.; Galon, J.; Puig, P. Laurent Share Save
Share Save
Dynamic changes in the tumor microenvironment from initial diagnosis through sequential therapies in patients with large B cell lymphoma undergoing axicabtagene ciloleucel (axi-cel) treatment Mattie, Michael; Perbost, Regis; Auguste, Aurelie; Turcan, Sarah; Kim, Jenny J.; To, Christina; Nater, Jenny; Filosto, Simone; Shen, Rhine R.; Galon, Jerome Share Save
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma Locke, Frederick L.; Filosto, Simone; Chou, Justin; Vardhanabhuti, Saran; Perbost, Regis; Dreger, Peter; Hill, Brian T.; Lee, Catherine; Zinzani, Pier L.; Kroeger, Nicolaus; Lopez-Guillermo, Armando; Greinix, Hildegard; Zhang, Wangshu; Tiwari, Gayatri; Budka, Justin; Marincola, Francesco M.; To, Christina; Mattie, Mike; Schupp, Marco; Cheng, Paul; Bot, Adrian; Shen, Rhine; Bedognetti, Davide; Miao, Harry; Galon, Jerome Share Save
Avelumab (AVE) combined with cetuximab (CET) and irinotecan (IRI) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): The AVETUXIRI phase II study van den Eynde, M.; Huyghe, N.; Sinapi, I.; De Cuyper, A.; Verstraelen, E.; Goffette, P.; Ghaye, B.; Papier, M.; Bedognetti, D.; van Maanen, A.; Castella, M-L.; Galon, J.; Carrasco, J. Share Save
Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial Huyghe, N.; Benidovskaya, E.; Masoodi, T.; Carrasco, J.; De Cuyper, A.; Sinapi, I.; Vempalli, F.; Verstraelen, E.; Goffette, P.; Ghaye, B.; Papier, M.; Bedognetti, D.; van Maanen, A.; Castella, M-L.; Galon, J.; van den Eynde, M. Share Save
Share Save
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy) Ascierto, Paolo A.; Agarwala, Sanjiv S.; Warner, Allison Betof; Ernstoff, Marc S.; Fox, Bernard A.; Gajewski, Thomas F.; Galon, Jerome; Garbe, Claus; Gastman, Brian R.; Gershenwald, Jeffrey E.; Kalinski, Pawel; Krogsgaard, Michelle; Leidner, Rom S.; Lo, Roger S.; Menzies, Alexander M.; Michielin, Olivier; Poulikakos, Poulikos I.; Weber, Jeffrey S.; Caraco, Corrado; Osman, Iman; Puzanov, Igor; Thurin, Magdalena Share Save
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer Ghiringhelli, Francois; Bibeau, Frederic; Greillier, Laurent; Fumet, Jean-David; Ilie, Alis; Monville, Florence; Lauge, Caroline; Catteau, Aurelie; Boquet, Isabelle; Majdi, Amine; Morgand, Erwan; Oulkhouir, Youssef; Brandone, Nicolas; Adam, Julien; Sbarrato, Thomas; Kassambara, Alboukadel; Fieschi, Jacques; Garcia, Stephane; Lepage, Anne Laure; Tomasini, Pascale; Galon, Jerome Share Save
FOLFOXIRI plus bevacizumab and atezolizumab as upfront treatment of unresectable mCRC patients: Updated and overall survival results of the phase II randomized AtezoTRIBE study Antoniotti, C.; Rossini, D.; Pietrantonio, F.; Salvatore, L.; Marmorino, F.; Ambrosini, M.; Lonardi, S.; Bensi, M.; Moretto, R.; Tamberi, S.; Toma, I.; Passardi, A.; De Grandis, M.; Conca, V.; Palermo, M.; Cappetta, A.; Catteau, A.; Boni, L.; Galon, J.; Cremolini, C. Share Save
Reuniting philosophy and science to advance cancer research Pradeu, Thomas; Daignan-Fornier, Bertrand; Ewald, Andrew; Germain, Pierre-Luc; Okasha, Samir; Plutynski, Anya; Benzekry, Sebastien; Bertolaso, Marta; Bissell, Mina; Brown, Joel S.; Chin-Yee, Benjamin; Chin-Yee, Ian; Clevers, Hans; Cognet, Laurent; Darrason, Marie; Farge, Emmanuel; Feunteun, Jean; Galon, Jerome; Giroux, Elodie; Green, Sara; Gross, Fridolin; Jaulin, Fanny; Knight, Rob; Laconi, Ezio; Larmonier, Nicolas; Maley, Carlo; Mantovani, Alberto; Moreau, Violaine; Nassoy, Pierre; Rondeau, Elena; Santamaria, David; Sawai, Catherine M.; Seluanov, Andrei; Sepich-Poore, Gregory D.; Sisirak, Vanja; Solary, Eric; Yvonnet, Sarah; Laplane, Lucie Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
